Adam Boshell, Director of Biosimilars Marketing, Boehringer Ingelheim
Adam Boshell, in his former role as Senior AD, ILD Marketing at Boehringer Ingelheim, was a marketer for OFEV, a treatment for Interstitial Lung Disease.
Adam used innovative technology to create compelling stories and beautifully rendered, immersive digital experiences. His goal? To connect OVEV with stakeholders through engaging, educational experiences that could be used in various ways throughout the campaign.
Adam developed an on-demand augmented reality immersive experience and interactive 3D website experience for OFEV providers. He then delivered the wow factor. OFEV Holographic Vignettes combined dynamic live-action HD volumetric video with interactive and animated medical media. Stakeholders at all levels experience 3D holograms—directly in the room with them. A Key Opinion Leader in Interstitial Lung Disease provided OFEV clinical information to the viewers via this volumetric video technology. The programs delivered core OFEV messaging in a memorable experience that drove confidence and improved retention.
The innovative approach taken by OFEV, under Adam’s guidance, was highly successful, especially in remote environments throughout COVID-19. As a leader, he empowered those around him to push creative technology limits that elevated storytelling. The result has been a series of highly innovative and effective tactical deployments, which helped deliver the message of OFEV for patients that need it.
Now, in his position as Director of Biosimilars Marketing, Adam continues to use innovative approaches to engage patients and providers. He is a genuine trailblazer who has demonstrated time and again his commitment to educating providers, and ultimately, providing better lives for those who depend on Boehringer Ingelheim’s healthcare solutions.
